A5008100526- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- COVID-19 and healthcare impacts
- Long-Term Effects of COVID-19
- Venous Thromboembolism Diagnosis and Management
- Nanoplatforms for cancer theranostics
- Cancer Research and Treatment
- Parasitic Infections and Diagnostics
- Inflammatory Biomarkers in Disease Prognosis
- Respiratory Support and Mechanisms
- Nanoparticle-Based Drug Delivery
- SARS-CoV-2 detection and testing
- Healthcare and Venom Research
- Insect and Pesticide Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Bee Products Chemical Analysis
Shahid Beheshti University of Medical Sciences
2021-2023
Masih Daneshvari Hospital
2021-2023
Abstract Some previous studies suggested that the plasma exchange (PE) and hemoperfusion (HP) played a cardinal role in treatment of severe coronavirus disease 2019 (COVID‐19) cases by diminishing cytokine storm. This study aimed to assess effects PE HP on storms patients with COVID‐19 through systematic scoping review. Four Electronic databases (Medline [accessed from PubMed], Scopus, Science Direct, Cochrane library) were searched systematically February 2, 2021, using MESH terms related...
Royal jelly, propolis, and bee pollen are used for different purposes all around the world according to their anti-inflammatory, antioxidant, antimicrobial activities. Given that Coronavirus 2019 (COVID-19) is a viral condition accompanied by dysregulated inflammatory response in body, we intend evaluate effects of natural supplementations on disease course. A randomized, open-label, controlled trial was conducted among 50 definitive cases COVID-19. These patients were randomly assigned into...
Background: Chronic obstructive pulmonary disease (COPD) is a chronic systemic inflammation, which has similar signs and symptoms to heart failure (CHF). Objective: To compare high-sensitive C-reactive protein (hsCRP) level selected blood indices in patients with COPD CHF. Methods: This prospective cross-sectional study (July 2019-July 2020) was conducted on aged 40-70 years old previous diagnosis of COPD, CHF, cor pulmonale. They were divided into four groups: 1) who hospitalized due...
: Since thrombosis occurrence among coronavirus disease 2019 (COVID-19) patients is a critical complication, this study aimed to describe the clinical characteristics and outcomes of COVID-19-associated pulmonary thromboembolism (PTE). This case series 39 venous (VTE) represents characteristics, laboratory data, imaging outcomes. The mean age was 55 ± 15 years. Moreover, 25 (64.10%) were male. most frequent COVID-19 presentations dyspnea cough in 22 (56.41%) 19 (48.71%) patients,...